Bumper Offer - Urjas oil Just @ Rs. 1
Olopat OD Eye Drop, a prescription drug, is manufactured in various forms such as Drops. Conjunctivitis are some of its major therapeutic uses. The alternative uses of Olopat OD Eye Drop have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Olopat OD Eye Drop. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Olopat OD Eye Drop as well, which are listed below. Such side effects of Olopat OD Eye Drop normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Olopat OD Eye Drop is Moderate for pregnant women and Moderate for women who are breastfeeding. It is important to know if Olopat OD Eye Drop has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Olopat OD Eye Drop related warnings section.
The section on Olopat OD Eye Drop contraindications lists all such conditions.
Besides this, Olopat OD Eye Drop may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Olopat OD Eye Drop is safe while driving, and is addiction.
Olopat OD Eye Drop is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Olopat OD Eye Drop is used -
Mild
Is the use of Olopat OD Eye Drop safe for pregnant women?
Olopat can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Olopat right away. Take your doctor's advice before taking it again.
Is the use of Olopat OD Eye Drop safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Olopat. Immediately discontinue Olopat if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Olopat OD Eye Drop on the Kidneys?
Olopat rarely affects the kidneys.
What is the effect of Olopat OD Eye Drop on the Liver?
Olopat may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Olopat OD Eye Drop on the Heart?
Using Olopat does not have any harmful effects on the heart.
Olopat OD Eye Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Olopat OD Eye Drop unless your doctor advises you to do so -
Is this Olopat OD Eye Drop habit forming or addictive?
No, you will not get addicted to Olopat OD Eye Drop.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Olopat OD Eye Drop since it will not make you feel sleepy.
Is it safe?
Yes, but take Olopat OD Eye Drop only as per medical advice.
Is it able to treat mental disorders?
Olopat OD Eye Drop is unable to treat or cure mental disorders.
Interaction between Food and Olopat OD Eye Drop
Information is not available on the interaction of any foods with Olopat OD Eye Drop, due to a lack of research on this.
Interaction between Alcohol and Olopat OD Eye Drop
No research has been done on this till date. Therefore, it is not known what the effect of taking Olopat OD Eye Drop with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1398
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pataday™ (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pazeo (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Patanol® (olopatadine hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1398
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pataday™ (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pazeo (olopatadine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Patanol® (olopatadine hydrochloride)
